Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies. J of Skin [Internet]. 2018 Feb. 23 [cited 2026 Apr. 25];2(S1):S4. Available from: https://skin.dermsquared.com/skin/article/view/252